by Device (incubators, cryosystem, imaging system, sperm separation system, micromanipulator system) Reagents & media (cryopreservation media, semen processing media, ovum processing media, and embryo culture media )End User (incubators, cryosystem, imaging system, sperm separation system, micromanipulator system)-Global Industry opportunities and Forecast 2016-2025
In Vitro Fertilization (IVF) process, a type of assisted reproductive technology (ART), has experienced a surge in demand owing to the increasing cases of infertility and growing healthcare expenditures. In this process, the ovum is fertilized artificially in a controlled laboratory setup, before being implanted into the uterus. IVF has largely benefitted couples with infertility problems, single mothers, and the LGBT sect of people.
The global IVF devices market is witnessing rapid growth due to the remarkable advancements in technology, that have led to an increase in the success rates of the technique. The changing lifestyles have resulted in delayed pregnancies in women, thus fueling the need for alternative methods. The rise in gamete donations also drives the markets growth. However, the high cost associated with the procedure acts as the major restraint. Multiple pregnancies and the ethical and legal issues involved in the IVF procedure limit the growth of the global In Vitro Fertilization devices market. Rise in fertility tourism along with the growing numbers of fertility clinics, across the globe, are expected to present numerous opportunities for the IVF devices market to grow. Growing prevalence of same-sex marriages also leads to the growth of the market.
The market is segmented based on the instruments, reagents & media, technique, end users, and the geography. The instruments available include incubators, cryosystem, imaging system, sperm separation system, micromanipulator system, and others. Accessories and disposables comprise of semen analysis chamber, plastic ware, and oocyte retrieval needles. The reagents & media segment include cryopreservation media, semen processing media, ovum processing media, and embryo culture media. Fresh embryo transfer (FER) and Donor Egg IVF techniques are used in the IVF process. End users include hospitals, surgical centers, clinical research institutes, and clinics. Based on the geography, the market is analyzed in the regions of North America, Asia-Pacific, Europe, and LAMEA.
The market is dominated by the leading players such as Ovascience Inc., Vitrolife AB, EMD Serono, Inc., Irvine Scientific, Cook Medical, Thermo Fisher Scientific Inc., Oxford Gene Technology, and Auxogyn, Inc. The information on the company profile, market share, latest developments, and the key winning strategies adopted by the key players of the market assist the potential investors and stakeholders in making informed decisions.
Key Benefits of the report
The United States Amniotic Membrane Market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Read More >>